FloraWorks | Bonaventure Equity Portfolio Company
FloraWorks Announces the Closing of Lead Investor In Series A Financing
FloraWorks is committed to exploring and developing new cannabinoids that have the potential to address various unmet medical needs. The FloraWorks’ team believe that the therapeutic utility of cannabinoids is far from fully understood and that they have the potential to provide solutions for a range of conditions, from sleep disorders to Alzheimer's disease.
The Company’s proprietary processing technologies and extensive research and development efforts are aimed at making these rare and novel cannabinoids viable for use in medical treatments.
Learn About FloraWorks
In the News:
FloraWorks Completes $2.25M Series-A Financing Led by Bonaventure Equity (BVE) For Cannabinoid Research
FloraWorks Announces Scientific Breakthrough in Natural Sleep Aids: First-Ever Double-Blind, Randomized, Placebo-Controlled Clinical Trial Discovers CBN Effective for Sleep
Cannabis Capital Podcast:
Website: